TC Biopharm (TCBP) - Earnings growth in current year

Corporate emblem and logo of TC BioPharm Ltd (TCBP)

TC Biopharm is implementing automated bioreactors to eliminate human error during cell creation. The annual EPS growth rate, illustrated by this chart from the GURU.Markets system—where the value 0.00 represents the current metric—confirms the commercialization potential of leukemia therapy. However, high production costs and the risk of more affordable alternatives create certain financial threats to the business.

TCBP - TC Biopharm Earnings growth in current year over the range 04/28/2023 - 03/29/2025

Financial and market metric breakdowns for TC Biopharm (TCBP)

- price and consensus price forecast:
Stock Quotes TC BioPharm (Holdings) Plc|TCBP - Consensus Target
- market capitalization indicators:
Market Capitalization TC Biopharm|TCBP - Total Company Value
- book capitalization data:
Equity per Share TC BioPharm|TCBP - Book Capitalization|Market-to-Book Ratio tcbiopharm.com|TCBP - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Capital TC Biopharm|TCBP - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio tcbiopharm.com|TCBP - Company Total Debt|Debt to Net Assets Ratio TC Biopharm|TCBP - Company Long-Term Debts|Company Short-Term Debt TC BioPharm|Interim Coverage Ratio tcbiopharm.com
- earnings and market ratios statistics:
TCBP - Company Net Income|Expected Net Profit TC Biopharm|TCBP - Price to Earnings Ratio|Price to Expected Earnings Ratio TC BioPharm Ltd|TCBP - PEG Multiple|Business Value to Operating Income Before Depreciation TC Biopharm|TCBP - Operating profit EBITDA|Net earnings per share (EPS TTM) TC BioPharm|TCBP - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months tcbiopharm.com|TCBP - Earnings per share growth in current year|Expected earnings per share growth for next year TC Biopharm
Summary company analysis:TC BioPharm (Holdings) Plc (TCBP)
Flagship merchandise of TC BioPharm

TC Biopharm specializes in developing innovative cell therapy methods and patenting immunity modification technologies to combat oncology. This metric digitizes the effectiveness of this intellectual property by measuring the annual percentage change in net income per share. Objective closing data strips the trajectory of manipulations, allowing a real-time assessment of the business model's capitalization through EPS YoY dynamics.

Direct competitors

Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|GRFS: Net earnings per share growth this year|Adaptive Biotechnologies Inc. - Net earnings per one share growth for the current year|CLDX: Earnings growth in current year|Net earnings per share growth this year auriniapharma.com|Net earnings per share growth this year BCRX|VERA: Earnings per share increase in current year|Earnings growth in current year DNTH|Earnings per share growth in current year PHVS (Pharvaris Pharma)|Earnings growth in current year ABCL (AbCellera Biologics)|Expected net earnings per share growth this year tourmalinebio.com (TRML)|PGEN - Earnings per share growth in current year|Earnings per share growth rate in current year Pharming Group NV|Nektar (NKTR) - Earnings per share growth in current year|Earnings per share trend in current year UPB (Upstream Pharma)|ZBIO (Zenas Biopharma Inc) - Earnings growth in current year|IMNM: Earnings per share increase in current year|Earnings growth in current year GOSS|Earnings growth in current year KalVista Pharma (KALV)|Earnings per share growth in current year Septerna Corp SEPN|Earnings per share increase in current year PVLA|SVRA - Earnings per share growth in current year|rigel.com (RIGL) - Net earnings per share growth this year|ANAB (AnaptysBio) - Net earnings per share growth this year|ATXS: Net earnings per one share growth for the current year|ENGN (enGene Bio) - Earnings growth in current year|Net earnings per share growth this year RAPT Therapeutics Inc. (RAPT)|Earnings growth in current year JBIO|Earnings per share growth in current year ACRS (aclaristx.com)|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|TLSA (Tiziana Life Sciences Ltd.) - Earnings per share trend in current year|CABA - Earnings per share growth in current year|Earnings per share trend in current year VTYX|THTX: Earnings growth in current year|avalotx.com - Earnings per share increase in current year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|Earnings growth in current year Agenus, Inc.|Earnings per share growth in current year Climb Bio, Inc. (CLYM)|ZURA (Zura Bio Ltd) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|ADAG - Net earnings per share growth this year|Ikena Oncology, Inc. - Earnings growth in current year|STTK - Earnings growth in current year|EQ (equilliumbio.com) - Net earnings per share growth this year|Connect Biopharma Holdings Limited - Earnings per share increase in current year|IMUX (Immunic Therapeutics) - Earnings growth in current year|Atara Biotherapeutics Inc (ATRA) - Expected net earnings per share growth this year|Earnings per share growth in current year InflaRx N.V. (IFRX)|Net earnings per share growth this year X4 Pharmaceuticals Inc. XFOR|Earnings per share growth in current year Adicet Bio, Inc. ACET|CELU - Net earnings per share growth this year|INMB: Net earnings per share growth this year|BRNS - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Earnings per share growth in current year|Earnings per share growth this year SABS|AKTX (Akari Therapeutics plc) - Earnings growth in current year|Earnings per share growth rate in current year Enlivex Therapeutics, Ltd. ENLV|Net earnings per share growth this year QTTB (Q32 Bio Inc.)|Net earnings per one share growth for the current year GOVX|Earnings growth in current year EDSA (Edesa Biotech)|IBIO - Net earnings per share growth this year|CARM: Net earnings per share growth this year|Earnings per share increase in current year XTLB (XTL Bio)|BOLT: Earnings growth in current year|HCWB (HCW Biologics) - Earnings per share growth in current year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth in current year|AIM ImmunoTech, Inc. (AIM) - Expected net earnings per share growth this year|Earnings per share growth in current year Aditxt (ADTX)|GRI - Earnings per share growth rate in current year|Earnings per share growth in current year XORTX Therapeutics Inc. XRTX|HIND (reshapelifesciences.com) - Earnings per share trend in current year|Revelation Biosciences, Inc. - Earnings growth in current year|Earnings per share increase in current year INDP (Indaptus Therapeutics Inc)|SCNI: Earnings growth in current year|CalciMedica (CALI) - Earnings growth in current year|Earnings per share growth in current year Affimed NV|ALLK: Earnings per share increase in current year|Earnings per share growth in current year HOOKIPA Pharma Inc. (HOOK)|Net earnings per share growth this year igmbio.com IGMS|iTeos - Net earnings per share growth this year|Net earnings per one share growth for the current year OCEA (Ocean Biomedical Corp)|Third Harmonic Bio - Earnings growth in current year